An olfactory neuroblastoma with intracranial extension treated with chemotherapy and radiotherapy: A case report
- Author:
Karen Mae D. Fortuno
1
;
Mary Ondinee Manalo Igot
2
Author Information
- Publication Type:Other Types
- Keywords: Intracranial extension; Case report
- MeSH: Esthesioneuroblastoma, Olfactory; Drug Therapy; Radiotherapy
- From: Philippine Journal of Health Research and Development 2021;25(3):94-104
- CountryPhilippines
- Language:English
-
Abstract:
Background:Olfactory neuroblastoma, also known as esthesioneuroblastoma, is a rare malignant tumor that presents as a locally aggressive disease. It accounts for an incidence of 0.4 per million population affecting men and women equally in all ages. As olfactory neuroblastoma is rare, having an intracranial extension is even more unusual. Only a few cases have been reported in literature, hence, there is no widely accepted standard of care.
Case Presentation:This is a case of a 33-year-old female who presented with a 4-month history of nasal congestion which progressed to a rapidly growing nasal mass and bilateral proptosis. She soon became bedridden and exhibited signs of increased intracranial pressure. Imaging revealed a heterogeneously enhancing nasal cavity mass with intracranial extension. Biopsy and immunohistochemistry confirmed the olfactory neuroblastoma. She subsequently underwent chemotherapy and radiotherapy since the tumor was unresectable. In a span of three months, after only three cycles of chemotherapy with cisplatin and etoposide and thirty fractions of radiation therapy, the patient significantly improved from being completely bedridden to an ambulatory individual capable of self-care. We completed eight cycles of chemotherapy and referred to surgical specialists for possible resectability. However, the patient did not consent for surgery and opted to have palliative care.
Conclusion:Most cases of olfactory neuroblastoma are treated through combination therapy. The patient significantly improved from the administration of chemotherapy with cisplatin and etoposide plus radiotherapy. This case report shows the significance of chemotherapy with radiotherapy as the treatment of choice for late-stage olfactory neuroblastoma in which surgery is not amenable. - Full text:502-1249-2-PB.pdf
